| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |


From the Department of Medicine,*
Cardiovascular
Division, Brigham and Womens Hospital, Harvard Medical School,
Boston, Massachusetts; the Department of Cardiovascular
Pathology,
Armed Forces Institute of
Pathology, Washington, District of Columbia; and the Department of
Medicine,
Washington University School of
Medicine, St. Louis, Missouri
Inflammation and oxidative stress contribute to the pathogenesis of many human diseases including atherosclerosis. Advanced human atheroma contains high levels of the enzyme myeloperoxidase that produces the pro-oxidant species, hypochlorous acid (HOCl). This study documents increased numbers of myeloperoxidase-expressing macrophages in eroded or ruptured plaques causing acute coronary syndromes. In contrast, macrophages in human fatty streaks contain little or no myeloperoxidase. Granulocyte macrophage colony-stimulating factor, but not macrophage colony-stimulating factor, selectively regulates the ability of macrophages to express myeloperoxidase and produce HOCl in vitro. Moreover, myeloperoxidase-positive macrophages in plaques co-localized with granulocyte macrophage colony-stimulating factor. Pro-inflammatory stimuli known to be present in human atherosclerotic plaque, including CD40 ligand, lysophosphatidylcholine, or cholesterol crystals, could induce release of myeloperoxidase from HOCl production by macrophages in vitro. HOCl-modified proteins accumulated at ruptured or eroded sites of human coronary atheroma. These results identify granulocyte macrophage colony-stimulating factor as an endogenous regulator of macrophage myeloperoxidase expression in human atherosclerosis and support a particular role for the myeloperoxidase-expressing macrophages in atheroma complication and the acute coronary syndromes.
This article has been cited by other articles:
![]() |
A. Mantovani, C. Garlanda, and M. Locati Macrophage Diversity and Polarization in Atherosclerosis: A Question of Balance Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1419 - 1423. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Rensen, Y. Slaats, J. Nijhuis, A. Jans, V. Bieghs, A. Driessen, E. Malle, J. W. Greve, and W. A. Buurman Increased Hepatic Myeloperoxidase Activity in Obese Subjects with Nonalcoholic Steatohepatitis Am. J. Pathol., October 1, 2009; 175(4): 1473 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ronald, J. W. Chen, Y. Chen, A. M. Hamilton, E. Rodriguez, F. Reynolds, R. A. Hegele, K. A. Rogers, M. Querol, A. Bogdanov, et al. Enzyme-Sensitive Magnetic Resonance Imaging Targeting Myeloperoxidase Identifies Active Inflammation in Experimental Rabbit Atherosclerotic Plaques Circulation, August 18, 2009; 120(7): 592 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ali, P. Sarcia, T. H Mosley, V. Kondragunta, and I. J Kullo Association of serum myeloperoxidase with the ankle-brachial index and peripheral arterial disease Vascular Medicine, August 1, 2009; 14(3): 215 - 220. [Abstract] [PDF] |
||||
![]() |
R. K. Schindhelm, L. P. van der Zwan, T. Teerlink, and P. G. Scheffer Myeloperoxidase: A Useful Biomarker for Cardiovascular Disease Risk Stratification? Clin. Chem., August 1, 2009; 55(8): 1462 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Terashima, Y. Ohashi, H. Azumi, K. Otsui, H. Kaneda, K. Awano, S. Kobayashi, T. Honjo, T. Suzuki, K. Maeda, et al. Impact of NAD(P)H Oxidase-Derived Reactive Oxygen Species on Coronary Arterial Remodeling: A Comparative Intravascular Ultrasound and Histochemical Analysis of Atherosclerotic Lesions Circ Cardiovasc Interv, June 1, 2009; 2(3): 196 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zulli, E. Lau, B. P.P. Wijaya, X. Jin, K. Sutarga, G. D. Schwartz, J. Learmont, P. J. Wookey, A. Zinellu, C. Carru, et al. High Dietary Taurine Reduces Apoptosis and Atherosclerosis in the Left Main Coronary Artery: Association With Reduced CCAAT/Enhancer Binding Protein Homologous Protein and Total Plasma Homocysteine but not Lipidemia Hypertension, June 1, 2009; 53(6): 1017 - 1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Nicholls and S. L. Hazen Myeloperoxidase, modified lipoproteins, and atherogenesis J. Lipid Res., April 1, 2009; 50(Supplement): S346 - S351. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sugamura, S. Sugiyama, T. Nozaki, Y. Matsuzawa, Y. Izumiya, K. Miyata, M. Nakayama, K. Kaikita, T. Obata, M. Takeya, et al. Activated Endocannabinoid System in Coronary Artery Disease and Antiinflammatory Effects of Cannabinoid 1 Receptor Blockade on Macrophages Circulation, January 6, 2009; 119(1): 28 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Bloomer and K. Fisher-Wellman The role of exercise in minimizing postprandial oxidative stress in cigarette smokers Nicotine Tob Res, January 1, 2009; 11(1): 3 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Shah, W. J. Kop, R. H. Christenson, D. B. Diercks, D. Kuo, S. Henderson, K. Hanson, M. R. Mehra, and C. R. deFilippi Lack of Diagnostic and Prognostic Utility of Circulating Plasma Myeloperoxidase Concentrations in Patients Presenting with Dyspnea Clin. Chem., January 1, 2009; 55(1): 59 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. McEvoy, A.-G. Taylor, J. A. Zavadzkas, I. M. Mains, R. L. Ford, R. E. Stroud, L. B. Jeffords, C. U. Beck, S. T. Reeves, and F. G. Spinale Aprotinin Exerts Differential and Dose-Dependent Effects on Myocardial Contractility, Oxidative Stress, and Cytokine Release After Ischemia-Reperfusion Ann. Thorac. Surg., August 1, 2008; 86(2): 568 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Gandley, J. Rohland, Y. Zhou, E. Shibata, G. F. Harger, A. Rajakumar, V. E. Kagan, N. Markovic, and C. A. Hubel Increased Myeloperoxidase in the Placenta and Circulation of Women With Preeclampsia Hypertension, August 1, 2008; 52(2): 387 - 393. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Marsche, P. G. Furtmuller, C. Obinger, W. Sattler, and E. Malle Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro Cardiovasc Res, July 1, 2008; 79(1): 187 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Libby, M. Nahrendorf, M. J. Pittet, and F. K. Swirski Diversity of Denizens of the Atherosclerotic Plaque: Not All Monocytes Are Created Equal Circulation, June 24, 2008; 117(25): 3168 - 3170. [Full Text] [PDF] |
||||
![]() |
J. Shih, S. A. Datwyler, S. C. Hsu, M. S. Matias, D. P. Pacenti, C. Lueders, C. Mueller, O. Danne, and M. Mockel Effect of Collection Tube Type and Preanalytical Handling on Myeloperoxidase Concentrations Clin. Chem., June 1, 2008; 54(6): 1076 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Tsuru, H Kondo, Y Hojo, M Gama, O Mizuno, T Katsuki, K Shimada, M Kikuchi, and T Yashiro Increased granzyme B production from peripheral blood mononuclear cells in patients with acute coronary syndrome Heart, March 1, 2008; 94(3): 305 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Brevetti, V. Schiano, E. Laurenzano, G. Giugliano, M. Petretta, F. Scopacasa, and M. Chiariello Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease Eur. Heart J., January 2, 2008; 29(2): 224 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Spagnoli, E. Bonanno, G. Sangiorgi, and A. Mauriello Role of Inflammation in Atherosclerosis J. Nucl. Med., November 1, 2007; 48(11): 1800 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ohayon, O. Dubreuil, P. Tracqui, S. Le Floc'h, G. Rioufol, L. Chalabreysse, F. Thivolet, R. I. Pettigrew, and G. Finet Influence of residual stress/strain on the biomechanical stability of vulnerable coronary plaques: potential impact for evaluating the risk of plaque rupture Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1987 - H1996. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. MacRitchie, A. A. Gardner, S. M. Prescott, and D. M. Stafforini Molecular basis for susceptibility of plasma platelet-activating factor acetylhydrolase to oxidative inactivation FASEB J, April 1, 2007; 21(4): 1164 - 1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zirlik, C. Maier, N. Gerdes, L. MacFarlane, J. Soosairajah, U. Bavendiek, I. Ahrens, S. Ernst, N. Bassler, A. Missiou, et al. CD40 Ligand Mediates Inflammation Independently of CD40 by Interaction With Mac-1 Circulation, March 27, 2007; 115(12): 1571 - 1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Shaposhnik, X. Wang, M. Weinstein, B. J. Bennett, and A. J. Lusis Granulocyte Macrophage Colony-Stimulating Factor Regulates Dendritic Cell Content of Atherosclerotic Lesions Arterioscler Thromb Vasc Biol, March 1, 2007; 27(3): 621 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, Z. Xie, R. Reece, D. Pimental, and M.-H. Zou Uncoupling of Endothelial Nitric Oxidase Synthase by Hypochlorous Acid: Role of NAD(P)H Oxidase-Derived Superoxide and Peroxynitrite Arterioscler Thromb Vasc Biol, December 1, 2006; 26(12): 2688 - 2695. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Kolodgie, A. P. Burke, K. S. Skorija, E. Ladich, R. Kutys, A. T. Makuria, and R. Virmani Lipoprotein-Associated Phospholipase A2 Protein Expression in the Natural Progression of Human Coronary Atherosclerosis Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2523 - 2529. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ditiatkovski, B.-H. Toh, and A. Bobik GM-CSF Deficiency Reduces Macrophage PPAR-{gamma} Expression and Aggravates Atherosclerosis in ApoE-Deficient Mice Arterioscler Thromb Vasc Biol, October 1, 2006; 26(10): 2337 - 2344. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Castellani, J. J. Chang, X. Wang, A. J. Lusis, and W. F. Reynolds Transgenic mice express human MPO -463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in -463G males J. Lipid Res., July 1, 2006; 47(7): 1366 - 1377. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Wildsmith, C. J. Albert, D. S. Anbukumar, and D. A. Ford Metabolism of Myeloperoxidase-derived 2-Chlorohexadecanal J. Biol. Chem., June 23, 2006; 281(25): 16849 - 16860. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Cameron, T. J. Mocatta, A. P. Pilbrow, C. M. Frampton, R. W. Troughton, A. M. Richards, and C. C. Winterbourn Angiotensin Type-1 Receptor A1166C Gene Polymorphism Correlates With Oxidative Stress Levels in Human Heart Failure Hypertension, June 1, 2006; 47(6): 1155 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Virmani, A. P. Burke, A. Farb, and F. D. Kolodgie Pathology of the vulnerable plaque. J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C13 - C18. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsimikas, J. T. Willerson, and P. M. Ridker C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C19 - C31. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Baldus, V. Rudolph, M. Roiss, W. D. Ito, T. K. Rudolph, J. P. Eiserich, K. Sydow, D. Lau, K. Szocs, A. Klinke, et al. Heparins Increase Endothelial Nitric Oxide Bioavailability by Liberating Vessel-Immobilized Myeloperoxidase Circulation, April 18, 2006; 113(15): 1871 - 1878. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Jaffer, P. Libby, and R. Weissleder Molecular and Cellular Imaging of Atherosclerosis: Emerging Applications J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1328 - 1338. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Takeshita, J. Byun, T. Q. Nhan, D. K. Pritchard, S. Pennathur, S. M. Schwartz, A. Chait, and J. W. Heinecke Myeloperoxidase Generates 5-Chlorouracil in Human Atherosclerotic Tissue: A POTENTIAL PATHWAY FOR SOMATIC MUTAGENESIS BY MACROPHAGES J. Biol. Chem., February 10, 2006; 281(6): 3096 - 3104. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. De Palma, F. Del Galdo, G. Abbate, M. Chiariello, R. Calabro, L. Forte, G. Cimmino, M. F. Papa, M. G. Russo, G. Ambrosio, et al. Patients With Acute Coronary Syndrome Show Oligoclonal T-Cell Recruitment Within Unstable Plaque: Evidence for a Local, Intracoronary Immunologic Mechanism Circulation, February 7, 2006; 113(5): 640 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. McCormick, F. Rahimi, Y. V. Bobryshev, K. Gaus, H. Zreiqat, H. Cai, R. S. A. Lord, and C. L. Geczy S100A8 and S100A9 in Human Arterial Wall: IMPLICATIONS FOR ATHEROGENESIS J. Biol. Chem., December 16, 2005; 280(50): 41521 - 41529. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Daugherty, N. R. Webb, D. L. Rateri, and V. L. King Thematic review series: The Immune System and Atherogenesis. Cytokine regulation of macrophage functions in atherogenesis J. Lipid Res., September 1, 2005; 46(9): 1812 - 1822. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Garcia de Tena, I. Kriszbacher, M. Koppan, J. Bodis, and G. K. Hansson Inflammation, Atherosclerosis, and Coronary Artery Disease N. Engl. J. Med., July 28, 2005; 353(4): 429 - 430. [Full Text] [PDF] |
||||
![]() |
S. J. Nicholls and S. L. Hazen Myeloperoxidase and Cardiovascular Disease Arterioscler Thromb Vasc Biol, June 1, 2005; 25(6): 1102 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. McMillen, J. W. Heinecke, and R. C. LeBoeuf Expression of Human Myeloperoxidase by Macrophages Promotes Atherosclerosis in Mice Circulation, May 31, 2005; 111(21): 2798 - 2804. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hakonarson, S. Thorvaldsson, A. Helgadottir, D. Gudbjartsson, F. Zink, M. Andresdottir, A. Manolescu, D. O. Arnar, K. Andersen, A. Sigurdsson, et al. Effects of a 5-Lipoxygenase-Activating Protein Inhibitor on Biomarkers Associated With Risk of Myocardial Infarction: A Randomized Trial JAMA, May 11, 2005; 293(18): 2245 - 2256. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Klebanoff Myeloperoxidase: friend and foe J. Leukoc. Biol., May 1, 2005; 77(5): 598 - 625. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Apple, A. H.B. Wu, J. Mair, J. Ravkilde, M. Panteghini, J. Tate, F. Pagani, R. H. Christenson, M. Mockel, O. Danne, et al. Future Biomarkers for Detection of Ischemia and Risk Stratification in Acute Coronary Syndrome Clin. Chem., May 1, 2005; 51(5): 810 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Witting, B. J. Wu, M. Raftery, P. Southwell-Keely, and R. Stocker Probucol Protects against Hypochlorite-induced Endothelial Dysfunction: IDENTIFICATION OF A NOVEL PATHWAY OF PROBUCOL OXIDATION TO A BIOLOGICALLY ACTIVE INTERMEDIATE J. Biol. Chem., April 22, 2005; 280(16): 15612 - 15618. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Shao, C. Bergt, X. Fu, P. Green, J. C. Voss, M. N. Oda, J. F. Oram, and J. W. Heinecke Tyrosine 192 in Apolipoprotein A-I Is the Major Site of Nitration and Chlorination by Myeloperoxidase, but Only Chlorination Markedly Impairs ABCA1-dependent Cholesterol Transport J. Biol. Chem., February 18, 2005; 280(7): 5983 - 5993. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Stocker, A. Huang, E. Jeranian, J. Y. Hou, T. T. Wu, S. R. Thomas, and J. F. Keaney Jr Hypochlorous Acid Impairs Endothelium-Derived Nitric Oxide Bioactivity Through a Superoxide-Dependent Mechanism Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): 2028 - 2033. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pennathur, C. Bergt, B. Shao, J. Byun, S. Y. Kassim, P. Singh, P. S. Green, T. O. McDonald, J. Brunzell, A. Chait, et al. Human Atherosclerotic Intima and Blood of Patients with Established Coronary Artery Disease Contain High Density Lipoprotein Damaged by Reactive Nitrogen Species J. Biol. Chem., October 8, 2004; 279(41): 42977 - 42983. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Vita, M.-L. Brennan, N. Gokce, S. A. Mann, M. Goormastic, M. H. Shishehbor, M. S. Penn, J. F. Keaney Jr, and S. L. Hazen Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans Circulation, August 31, 2004; 110(9): 1134 - 1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Hazen Myeloperoxidase and Plaque Vulnerability Arterioscler Thromb Vasc Biol, July 1, 2004; 24(7): 1143 - 1146. [Full Text] [PDF] |
||||
![]() |
S. Sugiyama, K. Kugiyama, M. Aikawa, S. Nakamura, H. Ogawa, and P. Libby Hypochlorous Acid, a Macrophage Product, Induces Endothelial Apoptosis and Tissue Factor Expression: Involvement of Myeloperoxidase-Mediated Oxidant in Plaque Erosion and Thrombogenesis Arterioscler Thromb Vasc Biol, July 1, 2004; 24(7): 1309 - 1314. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bergt, X. Fu, N. P. Huq, J. Kao, and J. W. Heinecke Lysine Residues Direct the Chlorination of Tyrosines in YXXK Motifs of Apolipoprotein A-I When Hypochlorous Acid Oxidizes High Density Lipoprotein J. Biol. Chem., February 27, 2004; 279(9): 7856 - 7866. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Kumar, F. J. Piedrafita, and W. F. Reynolds Peroxisome Proliferator-activated Receptor {gamma} Ligands Regulate Myeloperoxidase Expression in Macrophages by an Estrogen-dependent Mechanism Involving the -463GA Promoter Polymorphism J. Biol. Chem., February 27, 2004; 279(9): 8300 - 8315. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Brennan, M. S. Penn, F. Van Lente, V. Nambi, M. H. Shishehbor, R. J. Aviles, M. Goormastic, M. L. Pepoy, E. S. McErlean, E. J. Topol, et al. Prognostic Value of Myeloperoxidase in Patients with Chest Pain N. Engl. J. Med., October 23, 2003; 349(17): 1595 - 1604. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Thukkani, C. J. Albert, K. R. Wildsmith, M. C. Messner, B. D. Martinson, F.-F. Hsu, and D. A. Ford Myeloperoxidase-derived Reactive Chlorinating Species from Human Monocytes Target Plasmalogens in Low Density Lipoprotein J. Biol. Chem., September 19, 2003; 278(38): 36365 - 36372. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Palinski United They Go: Conjunct Regulation of Aortic Antioxidant Enzymes During Atherogenesis Circ. Res., August 8, 2003; 93(3): 183 - 185. [Full Text] [PDF] |
||||
![]() |
X. Fu, S. Y. Kassim, W. C. Parks, and J. W. Heinecke Hypochlorous Acid Generated by Myeloperoxidase Modifies Adjacent Tryptophan and Glycine Residues in the Catalytic Domain of Matrix Metalloproteinase-7 (Matrilysin): AN OXIDATIVE MECHANISM FOR RESTRAINING PROTEOLYTIC ACTIVITY DURING INFLAMMATION J. Biol. Chem., August 1, 2003; 278(31): 28403 - 28409. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Shishehbor, M.-L. Brennan, R. J. Aviles, X. Fu, M. S. Penn, D. L. Sprecher, and S. L. Hazen Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory Pathways Circulation, July 29, 2003; 108(4): 426 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Henderson, J. Byun, J. Takeshita, and J. W. Heinecke Phagocytes Produce 5-Chlorouracil and 5-Bromouracil, Two Mutagenic Products of Myeloperoxidase, in Human Inflammatory Tissue J. Biol. Chem., June 20, 2003; 278(26): 23522 - 23528. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Dollery, C. A. Owen, G. K. Sukhova, A. Krettek, S. D. Shapiro, and P. Libby Neutrophil Elastase in Human Atherosclerotic Plaques: Production by Macrophages Circulation, June 10, 2003; 107(22): 2829 - 2836. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Burke, R. Virmani, Z. Galis, C. C. Haudenschild, and J. E. Muller Task force #2--what is the pathologic basis for new atherosclerosis imaging techniques? J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1874 - 1886. [Full Text] [PDF] |
||||
![]() |
M. H. Shishehbor, R. J. Aviles, M.-L. Brennan, X. Fu, M. Goormastic, G. L. Pearce, N. Gokce, J. F. Keaney Jr, M. S. Penn, D. L. Sprecher, et al. Association of Nitrotyrosine Levels With Cardiovascular Disease and Modulation by Statin Therapy JAMA, April 2, 2003; 289(13): 1675 - 1680. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Naruko, M. Ueda, K. Haze, A. C. van der Wal, C. M. van der Loos, A. Itoh, R. Komatsu, Y. Ikura, M. Ogami, Y. Shimada, et al. Neutrophil Infiltration of Culprit Lesions in Acute Coronary Syndromes Circulation, December 3, 2002; 106(23): 2894 - 2900. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Van Lenten, A. C. Wagner, G.M. Anantharamaiah, D. W. Garber, M. C. Fishbein, L. Adhikary, D. P. Nayak, S. Hama, M. Navab, and A. M. Fogelman Influenza Infection Promotes Macrophage Traffic Into Arteries of Mice That Is Prevented by D-4F, an Apolipoprotein A-I Mimetic Peptide Circulation, August 27, 2002; 106(9): 1127 - 1132. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. K. Hansson, P. Libby, U. Schonbeck, and Z.-Q. Yan Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis Circ. Res., August 23, 2002; 91(4): 281 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Carlson, Y Raab, L Seveus, S Xu, R Hallgren, and P Venge Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis Gut, April 1, 2002; 50(4): 501 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Libby, P. M. Ridker, and A. Maseri Inflammation and Atherosclerosis Circulation, March 5, 2002; 105(9): 1135 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shihabi, W.-G. Li, F. J. Miller Jr., and N. L. Weintraub Antioxidant therapy for atherosclerotic vascular disease: the promise and the pitfalls Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H797 - H802. [Full Text] [PDF] |
||||
![]() |
J. M. Upston, X. Niu, A. J. Brown, R. Mashima, H. Wang, R. Senthilmohan, A. J. Kettle, R. T. Dean, and R. Stocker Disease Stage-Dependent Accumulation of Lipid and Protein Oxidation Products in Human Atherosclerosis Am. J. Pathol., February 1, 2002; 160(2): 701 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Pentikainen, K. Oorni, and P. T. Kovanen Myeloperoxidase and Hypochlorite, but Not Copper Ions, Oxidize Heparin-Bound LDL Particles and Release Them From Heparin Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 1902 - 1908. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Brown, E. M. Brunt, and J. W. Heinecke Immunohistochemical Detection of Myeloperoxidase and Its Oxidation Products in Kupffer Cells of Human Liver Am. J. Pathol., December 1, 2001; 159(6): 2081 - 2088. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zhang, M.-L. Brennan, X. Fu, R. J. Aviles, G. L. Pearce, M. S. Penn, E. J. Topol, D. L. Sprecher, and S. L. Hazen Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease JAMA, November 7, 2001; 286(17): 2136 - 2142. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. PFEIFFER, A. LASS, K. SCHMIDT, and B. MAYER Protein tyrosine nitration in mouse peritoneal macrophages activated in vitro and in vivo: evidence against an essential role of peroxynitrite FASEB J, November 1, 2001; 15(13): 2355 - 2364. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Herman, G. K. Sukhova, P. Libby, N. Gerdes, N. Tang, D. B. Horton, M. Kilbride, R. E. Breitbart, M. Chun, and U. Schonbeck Expression of Neutrophil Collagenase (Matrix Metalloproteinase-8) in Human Atheroma: A Novel Collagenolytic Pathway Suggested by Transcriptional Profiling Circulation, October 16, 2001; 104(16): 1899 - 1904. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. MERTENS and P. HOLVOET Oxidized LDL and HDL: antagonists in atherothrombosis FASEB J, October 1, 2001; 15(12): 2073 - 2084. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hurt-Camejo, G. Camejo, H. Peilot, K. Oorni, and P. Kovanen Phospholipase A2 in Vascular Disease Circ. Res., August 17, 2001; 89(4): 298 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pfeiffer, A. Lass, K. Schmidt, and B. Mayer Protein Tyrosine Nitration in Cytokine-activated Murine Macrophages. INVOLVEMENT OF A PEROXIDASE/NITRITE PATHWAY RATHER THAN PEROXYNITRITE J. Biol. Chem., August 31, 2001; 276(36): 34051 - 34058. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fu, S. Y. Kassim, W. C. Parks, and J. W. Heinecke Hypochlorous Acid Oxygenates the Cysteine Switch Domain of Pro-matrilysin (MMP-7). A MECHANISM FOR MATRIX METALLOPROTEINASE ACTIVATION AND ATHEROSCLEROTIC PLAQUE RUPTURE BY MYELOPEROXIDASE J. Biol. Chem., October 26, 2001; 276(44): 41279 - 41287. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |